The new centre is focused on pregnancy planning and screening for patients at high-risk of miscarriage, foetal genetic abnormalities, and preeclampsia. It will also offer prognosis and treatment for complications during pregnancy, delivery, and care for new-borns from 23 weeks of gestational age.

The Company’s total investment in opening the new centre amounted to ca. RUB15 mln.

Mark Kurtser, CEO at MDMG, said:

“We are committed to providing high-quality medical services in every situation, including the most challenging ones, as this is well-recognised on the market. Today, we once again confirm this by opening the new Miscarriage Treatment Centre at Russia’s first private maternity hospital – PMC, which has delivered around 30,000 babies to date.

“This is a specialised centre focused on providing care during complicated pregnancies and for premature children that is unparalleled in Russia due to its technical capabilities and the outstanding experience of our highly professional team.

“Today we have further demonstrated that MDMG does not only scale up existing medical technology, but also constantly developing new and unique methods".

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 32 modern healthcare facilities, including 4 hospitals and 28 outpatient clinics in Moscow and Moscow region, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, and Vladimir.

The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.